Payment overview · 2025
General Payments
$7.03
1 reported records · 1 companies
Healthcare provider profile · identity verified
Tanner M Miller, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · OLNEY, IL · NPI 1497135065
Verified facts
What the public records show
CMS Open Payments records show Tanner M Miller, M.D. received $7.03 in general payments during 2025 across 1 reported records.
Dynavax Technologies Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | Unresolved — no canonical attribution shown | $7.03 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $7.03 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Heplisav-B Normalized: heplisav b |
Drug | Dynavax Technologies Corporation | $7.03 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 723 | 170 |
| Pantoprazole Sodium | Pantoprazole Sodium | 461 | 101 |
| Amlodipine Besylate | Amlodipine Besylate | 431 | 107 |
| Levothyroxine Sodium | Levothyroxine Sodium | 429 | 94 |
| Gabapentin | Gabapentin | 424 | 80 |
| Losartan Potassium | Losartan Potassium | 375 | 87 |
| Lisinopril | Lisinopril | 352 | 92 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 338 | 67 |
| Metformin Hcl | Metformin Hcl | 300 | 70 |
| Omeprazole | Omeprazole | 289 | 66 |
| Furosemide | Furosemide | 283 | 80 |
| Potassium Chloride | Potassium Chloride | 283 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 261 | 57 |
| Montelukast Sodium | Montelukast Sodium | 248 | 52 |
| Trulicity | Dulaglutide | 248 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 219 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 202 | 66 |
| Alprazolam | Alprazolam | 193 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 191 | 41 |
| Tramadol Hcl | Tramadol Hcl | 185 | 42 |
| Citalopram Hbr | Citalopram Hydrobromide | 179 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 171 | 37 |
| Simvastatin | Simvastatin | 146 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 139 | 46 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 138 | 28 |
| Jardiance | Empagliflozin | 137 | 26 |
| Meloxicam | Meloxicam | 135 | 35 |
| Spironolactone | Spironolactone | 135 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 33 |
| Allopurinol | Allopurinol | 127 | 29 |
| Topiramate | Topiramate | 127 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 124 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 123 | 33 |
| Eliquis | Apixaban | 122 | 28 |
| Pregabalin | Pregabalin | 116 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 111 | 25 |
| Trazodone Hcl | Trazodone Hcl | 107 | 29 |
| Alendronate Sodium | Alendronate Sodium | 105 | 26 |
| Ezetimibe | Ezetimibe | 104 | 26 |
| Donepezil Hcl | Donepezil Hcl | 103 | 18 |
| Metformin Hcl Er | Metformin Hcl | 102 | 23 |
| Carvedilol | Carvedilol | 97 | 27 |
| Buspirone Hcl | Buspirone Hcl | 95 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 26 |
| Finasteride | Finasteride | 91 | 19 |
| Mirtazapine | Mirtazapine | 87 | 23 |
| Clonazepam | Clonazepam | 82 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 81 | 24 |
| Warfarin Sodium | Warfarin Sodium | 81 | 21 |
| Famotidine | Famotidine | 80 | 15 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 79 | 16 |
| Glipizide Er | Glipizide | 77 | 14 |
| Sertraline Hcl | Sertraline Hcl | 77 | 19 |
| Ventolin Hfa | Albuterol Sulfate | 77 | 13 |
| Lorazepam | Lorazepam | 72 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 69 | 14 |
| Celecoxib | Celecoxib | 68 | 22 |
| Glipizide | Glipizide | 68 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 66 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 66 | suppressed |
| Atenolol | Atenolol | 65 | 19 |
| Mounjaro | Tirzepatide | 62 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 61 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 61 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 61 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 60 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 59 | 15 |
| Prednisone | Prednisone | 56 | 34 |
| Dicyclomine Hcl | Dicyclomine Hcl | 54 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 11 |
| Memantine Hcl | Memantine Hcl | 52 | 11 |
| Ozempic | Semaglutide | 52 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 50 | 13 |
| Propranolol Hcl | Propranolol Hcl | 50 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 48 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 46 | 12 |
| Meclizine Hcl | Meclizine Hcl | 45 | 14 |
| Klor-Con M20 | Potassium Chloride | 44 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 22 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 42 | suppressed |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Lovastatin | Lovastatin | 42 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 41 | suppressed |
| Nystatin | Nystatin | 41 | 16 |
| Roflumilast | Roflumilast | 41 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 40 | 11 |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | 12 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 39 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 14 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 23 |
| Aimovig Autoinjector | Erenumab-Aooe | 34 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Fentanyl | Fentanyl | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Glimepiride | Glimepiride | 27 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 27 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | 11 |
| Wegovy | Semaglutide | 24 | suppressed |
| Ingrezza | Valbenazine Tosylate | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 20 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 21 |
| Arnuity Ellipta | Fluticasone Furoate | 21 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Admelog Solostar | Insulin Lispro | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Repatha Sureclick | Evolocumab | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Risperidone | Risperidone | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 13 |
| Diazepam | Diazepam | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Azithromycin | Azithromycin | 15 | 15 |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 15 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Klor-Con M10 | Potassium Chloride | 13 | suppressed |
| Probenecid | Probenecid | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Trokendi Xr | Topiramate | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $7.03 · 1 records | Dynavax Technologies Corporation | Heplisav-B | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error